Loading clinical trials...
Loading clinical trials...
A Phase IIa, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of the CRTh2 Antagonist AZD1981 in Patients With Chronic Idiopathic Urticaria (CIU) Who Are Refractory to H1 Antihistamines
Conditions
Interventions
AZD1981
Placebo
Locations
1
United States
Johns Hopkins Asthma and Allergy Center
Baltimore, Maryland, United States
Start Date
January 1, 2014
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
July 12, 2017
NCT03858634
NCT05774639
NCT03183024
NCT00866788
NCT02166151
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions